The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
FIERCE-HN: A multicenter, randomized, double-blind, placebo-controlled, phase 3 study of ficlatuzumab (HGF/cMET MAb) in combination with cetuximab in participants with recurrent or metastatic (R/M) HPV negative head and neck squamous cell carcinoma (HNSCC).
 
Julie Bauman
Consulting or Advisory Role - AVEO (Inst); BlueDot (Inst); Johnson & Johnson/Janssen
Research Funding - AVEO (Inst); BioNTech SE (Inst); Celldex (Inst); CUE Biopharma (Inst); Moderna Therapeutics (Inst)
 
Lisa Licitra
Honoraria - ALTIS Omnia Pharma Service Srl; Bristol Mayers Squibb [K.K.]; Merck KGaA; Merck Serono; MSD IT
Consulting or Advisory Role - Abbvie S.r.l.; ALX Oncology; Bicara Therapeutics; Boehringer Ingelheim; EMD Ser Reaserach & Development Institute Inc.; Genmab; GlaxoSmithKline; GroupH Ltd; Janssen Research & Development; Medscape LLC; Merck Healtcare KGaA; Merck Serono; MSD; MSD; Purple Biotech; Roche; Seagan
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Debiopharm Group (Inst); Eisai (Inst); Exelixis (Inst); IRX Therapeutics (Inst); Medpace (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Roche (Inst)
Travel, Accommodations, Expenses - TAE Life Sciences
 
Bhumsuk Keam
Honoraria - AstraZeneca; Bayer; LG Chem; MSD Oncology; Yuhan
Consulting or Advisory Role - Handok; ImmuneOncia; TiumBio; Trial Informatics; Yuhan
Research Funding - AstraZeneca; MSD Oncology; Ono Pharmaceutical
 
Jessica Bauman
Consulting or Advisory Role - Delcath Systems (I); EMD Serono; Pfizer
Travel, Accommodations, Expenses - Delcath Systems (I)
 
Victor Lin
No Relationships to Disclose
 
Neal Akhave
Honoraria - American Society of Clinical Oncology
Consulting or Advisory Role - Genmab/Seagen
Research Funding - AVEO (Inst); Bicara Therapeutics (Inst); Innocare (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - American Society of Clinical Oncology; Genmab/Seagen
 
Jérôme Fayette
Honoraria - Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Sanofi
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Merus NV; Seagen; Takeda
Travel, Accommodations, Expenses - Merck Serono; Merck Sharp & Dohme
 
Prakash Neupane
Research Funding - Merck Sharp & Dohme
 
Hussein Soudy
No Relationships to Disclose
 
Byoung Chul Cho
Employment - Yonsei University Health System
Leadership - J INTS BIO
Stock and Other Ownership Interests - Bridgebio; Cyrus therapeutics; Gencurix; Interpark Bio; J INTS BIO; Kanaph Therapeutics; Theravance
Consulting or Advisory Role - Amgen; AnHeart Therapeutics; ArriVent Biopharma; AstraZeneca; BeiGene; BMS; Boehringer Ingelheim; Bridgebio; CJ bioscience; Cyrus therapeutics; Cyrus therapeutics; Daiichi Sankyo; Gilead Sciences; GlaxoSmithKline; Guardant Health; Harpoon Therapeutics; J INTS Bio; Janssen; Kanaph Therapeutics; Lilly; MSD; Novartis; Ono Pharmaceutical; Pfizer; Regeneron; Roche; Sanofi; Seagen; Takeda; Therapex Co., Ltd; Yuhan
Research Funding - AstraZeneca; Champions Oncology; CJ bioscience; Cyrus Therapeutics; Dong-A ST; GI Innovation; ImmuneOncia; J Ints Bio; Janssen; MSD; Therapex; Vertical Bio AG; Yuhan
Patents, Royalties, Other Intellectual Property - Champions Oncology; Crown Bioscience; Imagen; PearlRiver Bio GmbH
Other Relationship - DAAN Biotherapeutics
 
Christine Chung
Consulting or Advisory Role - AVEO; Bicara Therapeutics; Exelixis; Fulgent Pharma; Genmab; Johnson & Johnson/Janssen; Regeneron; Seagen
Research Funding - Acrivon Therapeutics (Inst); Regeneron (Inst)
 
Nabil Saba
Honoraria - Coherus Biosciences; EMD Serono; Exelixis; Fulgent Pharma; GlaxoSmithKline; Merck; Nanobiotix; Novartis; Surface Oncology; TOSK
Consulting or Advisory Role - Akeso Biopharma; Fulgent Pharma; Seagen
Research Funding - Bristol-Myers Squibb; Exelixis
Patents, Royalties, Other Intellectual Property - Springer textbook Royalty; Uptodate chapter writing and editing
Travel, Accommodations, Expenses - Merck
 
Deborah Wong
Consulting or Advisory Role - Coherus Biosciences; Merck; RAPT Therapeutics
Research Funding - AstraZeneca/MedImmune (Inst); Bicara Therapeutics (Inst); BioNTech SE (Inst); Bristol-Myers Squibb (Inst); Elevar Therapeutics (Inst); Enzychem Lifesciences (Inst); Flamingo Pharma (Inst); FSTAR (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Hookipa Biotech (Inst); invoX pharma (Inst); Lilly; Lilly (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Regeneron (Inst); Sensei Biotherapeutics (Inst); TopAlliance BioSciences Inc (Inst)
 
Kevin Harrington
Honoraria - Abbvie (Inst); ALX Oncology (Inst); AstraZeneca (Inst); BeiGene (Inst); Bicara Therapeutics (Inst); BMS (Inst); Boehringer Ingelheim (Inst); Exelixis (Inst); Flamingo Pharma (Inst); GlaxoSmithKline (Inst); Johnson and Johnson (Inst); Merck Serono (Inst); Merus (Inst); MSD (Inst); Nanobiotix (Inst); PDS Biotechnology (Inst); PsiVac Ltd (Inst); Replimune (Inst); Scenic Biotech
Consulting or Advisory Role - AstraZeneca (Inst); BMS (Inst); Boehringer Ingelheim (Inst); Merck Serono (Inst); MSD (Inst); Nanobiotix (Inst); Replimune (Inst)
Speakers' Bureau - BMS (Inst); Merck Serono (Inst); MSD (Inst)
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Replimune (Inst)
 
Christophe Le Tourneau
Honoraria - Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Merck Serono; MSD; Nanobiotix; Novartis; Rakuten Medical; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Merck Serono; MSD; Nanobiotix; Roche; Seagen
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD
 
Suzy Muggeo
Employment - AVEO
 
Bo Jin
Employment - AVEO; SinoCellTech Group Ltd.; Sumitomo Pharma Oncology
 
Claudia Lebedinsky
Employment - AVEO; Sumitomo Dainnipon Pharma Oncology
Consulting or Advisory Role - Sumitomo Pharma Oncology
Patents, Royalties, Other Intellectual Property - US patent application submitted, title: Methods of treating myeloproliferative neoplasms. Pending patent.
 
Edgar Braendle
Employment - NewYork-Presbyterian/Columbia University Irving Medical Center (I)
Stock and Other Ownership Interests - Autolus Ltd The Mediaworks 191 Wood Lane White City London W12 7FP
Consulting or Advisory Role - Autolus Ltd The Mediaworks 191 Wood Lane White City London W12 7FP
 
Robert Haddad
Employment - Dana-Farber Cancer Institute
Leadership - NCCN
Stock and Other Ownership Interests - tosk
Consulting or Advisory Role - ALX Oncology; AstraZeneca; aveo; Bayer; Boehringer Ingelheim; Eisai; EMD Serono; Genmab; Genzyme; GlaxoSmithKline; Johnson & Johnson/Janssen; Merck; PDS Biotechnology; Scholar Rock
Research Funding - AstraZeneca (Inst); AVEO (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Kura Oncology (Inst); Merck (Inst); Merus (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
Other Relationship - Boehringer Ingelheim; Hookipa Pharma; ISA Pharmaceuticals; Nanobiotix